131 related articles for article (PubMed ID: 19513527)
1. Vascular endothelial growth inhibitor in human cancer (Review).
Zhang N; Sanders AJ; Ye L; Jiang WG
Int J Mol Med; 2009 Jul; 24(1):3-8. PubMed ID: 19513527
[TBL] [Abstract][Full Text] [Related]
2. Advancement in the research on vascular endothelial growth inhibitor (VEGI).
Duan L; Yang G; Zhang R; Feng L; Xu C
Target Oncol; 2012 Mar; 7(1):87-90. PubMed ID: 22388993
[TBL] [Abstract][Full Text] [Related]
3. VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growth.
Hou W; Medynski D; Wu S; Lin X; Li LY
Clin Cancer Res; 2005 Aug; 11(15):5595-602. PubMed ID: 16061878
[TBL] [Abstract][Full Text] [Related]
4. A novel secreted splice variant of vascular endothelial cell growth inhibitor.
Chew LJ; Pan H; Yu J; Tian S; Huang WQ; Zhang JY; Pang S; Li LY
FASEB J; 2002 May; 16(7):742-4. PubMed ID: 11923219
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential of VEGI/TL1A in Autoimmunity and Cancer.
Sethi G; Sung B; Aggarwal BB
Adv Exp Med Biol; 2009; 647():207-15. PubMed ID: 19760077
[TBL] [Abstract][Full Text] [Related]
6. Dual function of RGD-modified VEGI-192 for breast cancer treatment.
Wu J; Jiang Y; Yang W; He Z; Meng S; Zhang Q; Lin M; Zhang H; Li W; Yang Y; Jia Y; Qian L; Lu D; Cai W; Luo G; Wang Y; Zhu X; Li M
Bioconjug Chem; 2012 Apr; 23(4):796-804. PubMed ID: 22455451
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells.
Kumanishi S; Yamanegi K; Nishiura H; Fujihara Y; Kobayashi K; Nakasho K; Futani H; Yoshiya S
Int J Oncol; 2019 Jul; 55(1):167-178. PubMed ID: 31180533
[TBL] [Abstract][Full Text] [Related]
8. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo.
Zhai Y; Ni J; Jiang GW; Lu J; Xing L; Lincoln C; Carter KC; Janat F; Kozak D; Xu S; Rojas L; Aggarwal BB; Ruben S; Li LY; Gentz R; Yu GL
FASEB J; 1999 Jan; 13(1):181-9. PubMed ID: 9872942
[TBL] [Abstract][Full Text] [Related]
9. The differential expression of vascular endothelial growth inhibitor isoforms, VEGI251, VEGI174 and VEGI192 in human clear-cell renal cell carcinoma.
Zhang N; Wu P; Wu L; Shayiremu D; Shan H; Ye L; Jiang WG; Gong K; Yang Y
Cancer Genomics Proteomics; 2013; 10(1):47-53. PubMed ID: 23382586
[TBL] [Abstract][Full Text] [Related]
10. Distinct Expression Patterns of Two Tumor Necrosis Factor Superfamily Member 15 Gene Isoforms in Human Colon Cancer.
Ślebioda TJ; Stanisławowski M; Cyman M; Wierzbicki PM; Żurawa-Janicka D; Kobiela J; Makarewicz W; Guzek M; Kmieć Z
Dig Dis Sci; 2019 Jul; 64(7):1857-1867. PubMed ID: 30788683
[TBL] [Abstract][Full Text] [Related]
11. Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells.
Yamanegi K; Kawabe M; Futani H; Nishiura H; Yamada N; Kato-Kogoe N; Kishimoto H; Yoshiya S; Nakasho K
Int J Oncol; 2015 May; 46(5):1994-2002. PubMed ID: 25778932
[TBL] [Abstract][Full Text] [Related]
12. [Effect of N-terminal deletion on biological activity of vascular endothelial cell growth inhibitor].
Zhang M; Wang L; Wang HW; Pan X; Pan W; Qi ZT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):133-7. PubMed ID: 12545219
[TBL] [Abstract][Full Text] [Related]
13. VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis.
Xiao T; Fan JK; Huang HL; Gu JF; Li LY; Liu XY
Cell Res; 2010 Mar; 20(3):367-78. PubMed ID: 19918267
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesis.
Metheny-Barlow LJ; Li LY
Semin Ophthalmol; 2006; 21(1):49-58. PubMed ID: 16517446
[TBL] [Abstract][Full Text] [Related]
15. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.
Ma W; Li G; Wang J; Yang W; Zhang Y; Conti PS; Chen K
Amino Acids; 2014 Dec; 46(12):2721-32. PubMed ID: 25182731
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors.
Liang PH; Tian F; Lu Y; Duan B; Stolz DB; Li LY
Angiogenesis; 2011 Mar; 14(1):61-8. PubMed ID: 21188501
[TBL] [Abstract][Full Text] [Related]
17. The role of vascular endothelial growth factor and vascular endothelial growth inhibitor in clinical outcome of traumatic brain injury.
Li M; Jia Q; Chen T; Zhao Z; Chen J; Zhang J
Clin Neurol Neurosurg; 2016 May; 144():7-13. PubMed ID: 26945876
[TBL] [Abstract][Full Text] [Related]
18. Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor.
Zhang N; Wu P; Shayiremu D; Wu L; Shan H; Ye L; Zhao X; Cai J; Jiang WG; Gong K; Yang Y
Int J Oncol; 2013 May; 42(5):1664-73. PubMed ID: 23545578
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of endothelial cells to VEGI-induced apoptosis by inhibiting the NF-kappaB pathway.
Grimaldo S; Tian F; Li LY
Apoptosis; 2009 Jun; 14(6):788-95. PubMed ID: 19418226
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth inhibitor, expression in human prostate cancer tissue and the impact on adhesion and migration of prostate cancer cells in vitro.
Zhang N; Sanders AJ; Ye L; Kynaston HG; Jiang WG
Int J Oncol; 2009 Dec; 35(6):1473-80. PubMed ID: 19885571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
